Eledon Pharmaceuticals, Inc. (ELDN): Total Assets
$169.01M
As of 2025-12-31
$126.09M
As of 2026-06-30
+22.1%
3-year compound annual growth
-3.0%
5-year compound annual growth
+9.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $169.01M | -4.7% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $177.41M | +99.2% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $89.07M | -4.0% | 2025-08-14, Balance as of period end |
| 2022-12-31 | $92.79M | -45.6% | 2024-08-19, Balance as of period end |
| 2021-12-31 | $170.55M | -13.5% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $197.19M | n/m | 2022-03-24, Balance as of period end |
| 2019-12-31 | $10.93M | -35.8% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $17.03M | -18.5% | 2020-03-17, Balance as of period end |
| 2017-12-31 | $20.89M | n/m | 2019-03-28, Balance as of period end |
| 2016-12-31 | $1.20M | -98.2% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $67.97M | -36.9% | 2017-03-03, Balance as of period end |
| 2014-12-31 | $107.74M | +233.7% | 2016-03-10, Balance as of period end |
| 2013-12-31 | $32.29M | n/a | 2015-03-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $169.01M | -4.7% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $168.19M | +7.9% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $167.74M | -22.8% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $166.13M | +32.5% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $172.25M | -45.4% |
| PepGen Inc. (PEPG) | 2025-12-31 | $173.91M | +15.3% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $164.18M | n/m |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $163.18M | +232.2% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $162.40M | n/m |
Compare ELDN, CRBP, CLYM, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗